Stay updated on Psilocybin in OCD: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Psilocybin in OCD: Efficacy Study Clinical Trial page.

Latest updates to the Psilocybin in OCD: Efficacy Study Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedA new changelog entry 'Revision: v3.4.2' was added and the previous 'Revision: v3.4.1' entry was removed.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 appears on the page, replacing the previous v3.4.0; this is a minor metadata update that does not affect study content or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a Show glossary control and capitalization adjustments in metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data). The page revision is now Revision: v3.4.0.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section listing Connecticut (New Haven) as a study site, replacing the old Connecticut Locations label. The footer no longer includes the HHS Vulnerability Disclosure link, and the revision is updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Psilocybin in OCD: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin in OCD: Efficacy Study Clinical Trial page.